Invanz

This page contains recent news articles, when available, and an overview of Invanz but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Merck Announces Third-Quarter 2009 Financial Results  -  ‎Oct 22, 2009‎
INVANZ, ISENTRESS, MAXALT, PRIMAXIN, PROPECIA, PROSCAR, STOCRIN, TIMOPTIC/TIMOPTIC XE, TREDAPTIVE, TRUSOPT, VASOTEC/VASERETIC, ZOCOR and ZOLINZA. ... Reuters

FDA Approves New Indication for INVANZ(R) (ertapenem) for the …  -  Nov 14, 2005
WHITEHOUSE STATION, NJ -- Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) has approved INVANZ(R) (ertapenem), a once-daily ... Free with registration - Business Wire - AccessMyLibrary.com

Press Release: FDA Approves New Indication for INVANZ  -  Dec 20, 2006
WHITEHOUSE STATION, NJ--(BUSINESS WIRE)--Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) recently approved INVANZ® ... FierceBiotech

MSD India launches Invanz  -  Aug 11, 2007
Merck Sharp and Dohme Pharmaceuticals (MSD India) has launched its registered injectable Invanz in India. The wholly owned subsidiary of US drug maker Merck ... Hindu Business Line

FDA Approves New Indication For INVANZ® (ertapenem) For The …  -  Dec 28, 2006
Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) recently approved INVANZ® (ertapenem), a once-daily injectable antibiotic, ... Medical News Today - Medical News Today (press release)

Article: New indication for Invanz.(PRODUCTS)(Brief article) -...  -  Apr 1, 2007
New indication for Invanz.(PRODUCTS)(Brief article) ... find Internal Medicine News articles. Invanz (ertapenem), a once-daily injectable antibiotic, ... Pay-Per-View - Internal Medicine News - HighBeam Research

MSD India launches Invanz  -  Sep 15, 2007
MSD India, a wholly owned subsidiary of US drug maker Merck & Co, has launched Invanz in India. Invanz is a broad-spectrum, injectable, ... Express Pharma

INVANZ approved for complicated foot infection in diabetic patients.(...  -  Feb 1, 2006
INVANZ is a carbapenem antibiotic administered intravenously or ... Patients either received INVANZ 1 gram daily or piperacillin/tazobactam at the ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens ... Free with registration - Formulary - AccessMyLibrary.com

Merck Recalls 3 Lots of Invanz (ertapenem sodium) Injection Because...  -  Jul 5, 2007
BETHESDA, MD -- July 5, 2007 -- Merck and US Food and Drug Administration (FDA) informed healthcare professionals that three lots of Invanz (0803930, ... DG News

FDA Approvals: Exjade, Oncaspar, Invanz  -  Nov 17, 2005
Nov. 17, 2005 — The US Food and Drug Administration (FDA) has approved deferasirox tablets for oral suspension for the treatment of chronic transfusional ... Medscape

Merck's Invanz gains FDA approval for treatment of foot infections.  -  Nov 28, 2005
US drug major Merck & Co says the Food and Drug Administration has approved Invanz (ertapenem), the firm's once-daily injectable antibiotic, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Invanz Recall  -  Jul 10, 2007
Merck is informing health care providers that 3 lots (0803930, 0803940, and 0803950) of Invanz (ertapenem), have been recalled due to 2 reports of broken ... Facts and Comparisons

Merck Antibiotic Approved in US  -  Dec 22, 2006
Merck & Co. has said that the FDA has approved Invanz, a once-daily injectable ... In the study, a statistically significant difference favoring Invanz over ... RedOrbit

… Complications; US FDA approves INVANZ for treatment complicated...  -  Dec 13, 2005
2005 DEC 13 - (NewsRx.com) -- Merck & Co., Inc. announced that the US Food & Drug Administration (FDA) has approved INVANZ (ertapenem), a once-daily ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

New indication for Invanz.(PRODUCTS)(Brief article)  -  Apr 1, 2007
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved for the prevention of surgical site infections after elective colorectal surgery ... $4.95 - Internal Medicine News - ECNext

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens ... $4.95 - Formulary - ECNext

Invanz.  -  Jan 22, 2007
Invanz. FDA has granted to Merck & Co., Whitehouse Station, N.J., (908) 423-1000, a new indication for Invanz (ertapenem). The injectable antibiotic is now ... $9.94 - Drug Topics - Alacra Store

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections. ... $9.94 - Formulary - Alacra Store

Invanz.(NEW INDICATION)(Brief article)  -  Jan 22, 2007
FDA has granted to Merck & Co., Whitehouse Station, NJ, (908) 423-1000, a new indication for Invanz (ertapenem). The injectable antibiotic is now indicated ... $4.95 - Drug Topics - ECNext

Invanz: ertapenem for injection.(New indications)(Drug overview)  -  Feb 1, 2007
MERCK Ertapenem, a sterile, synthetic, parenteral, 1-beta methyl-carbapenem, is structurally related to beta-lactam antibiotics. This agent has demonstrated ... $4.95 - Formulary - ECNext

Drug Approvals  -  Nov 15, 2005
The FDA has approved Merck's Invanz (ertapenem), a once-daily injectable ... Invanz is already FDA approved to treat certain bacterial infections of the ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Merck receives US FDA approval for ertapenem  -  Dec 26, 2006
Invanz provides proven prophylaxis for elective colorectal surgery in a single 1 ... Invanz is now indicated in adults for the prophylaxis of surgical site ... pharmabiz.com

Ð?нтибиотик INVANZ® зарегиÑ?трирован в СШÐ?  -  Dec 25, 2006
КомпаниÑ? Merck & Co., Inc. Ñ?ообщила, что FDA разрешило применение препарата INVANZ® (Еrtapenem) длÑ? профилактики хирургичеÑ?кой раневой инфекции у взроÑ?лых, ... ФармацевтичеÑ?кий веÑ?тник

Merck to roll out money-spinning drugs soon  -  Mar 19, 2007
Invanz, the drug used to treat community-acquired pneumonia, ... Both Cosopt and Invanz, though having patent protection in key international markets, ... Business Standard

Once-Daily IV Antibiotic Effective for Diabetic Foot Infections  -  Nov 10, 2005
The clinical response rate for Invanz was 94% versus a 92% response rate for ... The study randomized 295 patients to Invanz (1 g daily) and 291 patients to ... MedPage Today

Prevención del pie diabético y mutilaciones relacionadas centra la …  -  Nov 6, 2005
...lo que hace que se requiera de antibióticos de amplio espectro con bajo patrón de resistencia, como Ertapenem, MSD, conocido comercialmente como INVANZ. ... El Observador - El Observador (Venezuela)

FDA Issues MedWatch Alerts for Two Injectable Antibiotics  -  Jul 13, 2007
Invanz, which is indicated for the treatment of moderate-to-severe infections, had sales of $23 million in the US during the first quarter of 2007, ... FDA news - FDA news (subscription)

IDSA releases guidelines for the diagnosis and treatment of skin and...  -  Oct 1, 2006
...or ertapenem (Invanz; see Table 3). Cefoxitin (Mefoxin) or carbapenem antibiotics could be used parenterally in patients with mild penicillin allergies. ... Free with registration - American Family Physician - AccessMyLibrary.com

ertapenem Merck & Co marketed, Hong Kong, Estonia (bacterial infection...  -  Jan 10, 2005
In 2004 Merck & Co launched the injectable broad spectrum carbapenem, ertapenem (INVANZ), as a potential treatment for bacterial infections in Estonia and ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Federal Register 2006 - 71 FR 5667 Summaries of Medical and Clinical ...  -  Feb 2, 2006
...reviews of pediatric studies submitted in supplements for INVANZ (ertapenem), KEPPRA (levetiracetam), TRILEPTAL (Oxcarbazepine), and ZYVOX (linezolid). ... Pay-Per-View - Federal Register 2006 - Loislaw

IDSA releases guidelines for the diagnosis and treatment of skin and...  -  Oct 1, 2006
...or ertapenem (Invanz; see Table 3). Cefoxitin (Mefoxin) or carbapenem antibiotics could be used parenterally in patients with mild penicillin allergies. ... $4.95 - American Family Physician - ECNext

New indication for Zemplar.(PRODUCTS)(Brief Article) | Article from …  -  Oct 1, 2005
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved ... Invanz is made by Merck & Co. Inc. For more information, visit www.invanz.com. ... Pay-Per-View - Internal Medicine News - HighBeam Research

New indication for avandia.(PRODUCTS)(Brief Article) | Article from …  -  May 1, 2005
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved ... Invanz is made by Merck & Co. Inc. For more information, visit www.invanz.com. ... Pay-Per-View - Internal Medicine News - HighBeam Research

Antibiotic and Antiviral Drug Classes  -  Apr 14, 2008
Carbapenems include meropenem (Merrem), biapenem, faropenem, ertapenem (Invanz) and combinations (imipenem/cilastatin [Primaxin]). These agents cover a wide ... New York Times

Phila. firm takes over Merck drug plant  -  Jan 3, 2008
...which makes intermediate compounds for two antibiotics, Invanz and Primaxin. The site also makes Merck's new cholesterol drug, MK524, and Avermectin, ... $2.95 - Philadelphia Inquirer - NewsBank

MSD Chibret inaugure une nouvelle production à... - Chimie  -  Nov 26, 2007
C'est la deuxième ligne de production de l'antibiotique Invanz qui n'a jamais servi. En effet, l'Invanz n'a pas atteint son objectif de production de 20 ... L'Usine Nouvelle

Factiva Search  -  Dec 27, 2006
FDA APPROVES NEW INDICATION FOR MERCK'S INVANZ. 27 December, 2006 ... The FDA has approved Merck's Invanz (ertapenem), a once-daily injectable antibiotic, ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

Skystar Bio-Pharmaceutical Projects Fourth Quarter Revenue Increase …  -  Dec 21, 2006
Third-quarter sales of Invanz rose 47 percent to $37 million. Abbott Laboratories (NYSE: ABT) will present at the 2007 JP Morgan Healthcare Conference on ... $4.95 - M2 Presswire - ECNext

EMEA Adopts Positive Opinion On Neupro (Parkinson's Disease) And …  -  Dec 17, 2005
Invanz (ertapenem), Merck Sharp & Dohme, to extend its indication to add ... Invanz was first authorised in the European Union on 18 April 2002 and is ... Medical News Today - Medical News Today (press release)

Press Release: Skystar Bio-Pharmaceutical Projects Fourth Quarter …  -  Dec 21, 2006
Third-quarter sales of Invanz rose 47 percent to $37 million. Abbott Laboratories (NYSE: ABT) will present at the 2007 JP Morgan Healthcare Conference on ... Pay-Per-View - M2 Presswire - HighBeam Research

E. Coli Bacteria May Become New 'Superbug,' Lancet Review Says  -  Feb 20, 2008
...s Invanz and AstraZeneca Plc's Merrem, are now used to fight serious infections with this strain of bacteria. Increased use of this type of drug, ... Arizona Daily Star

Stocks to Watch, Dec. 21: Red Hat, Bed Bath & Beyond  -  Dec 21, 2006
...(MRK) said the Food and Drug Administration approved Invanz, an injectable antibiotic, for the prevention of surgical site infections after elective ... FOXNews

Company Profile Report  -  Apr 5, 2008
Invanz (Ertapenem Sodium). Diabetic Nephropathy. Angiotensin II Receptor Antagonists. Products:. Cozaar (Losartan Potassium). Non-Insulin Dependent Diabetes ... $50.00 - Revere Reports - Revere

Ertapenem approvato per il piede diabetico  -  Nov 15, 2005
Disco verde della Food and Drug Administration Usa per l'antibiotico iniettabile Invanz* (ertapenem), per il trattamento delle infezioni ai piedi associate ... Pharma Marketing

Press Release: Carbapenem Drug Class Shows an Increase in Hospital …  -  Nov 6, 2008
...followed by AstraZeneca's Merrem/Meronem (meropenem) (36 percent) and Merck's Invanz (ertapenem injectable) (10 percent)," stated Joyce Wedemeyer, ... Pay-Per-View - PR Newswire - HighBeam Research

Article: PRODUCT RECALLS - The Washington Post | HighBeam …  -  Jul 6, 2007
DETAILS: Merck recalled three lots of the injected antibiotic Invanz. REASON: Broken glass was twice found in the solu... Pay-Per-View - Washington Post - HighBeam Research

It's Easy to Miss the Memo on Product Recalls  -  Aug 16, 2007
The action was taken after the antibiotic solution in Invanz Injections was found to contain glass pieces. Canned food. Castleberry Food Company recalled ... NPR

Merck re-enters Indian market  -  Jul 23, 2005
This will be followed by the launch of Invanz (a second generation beta-lactam anti-biotic) and Cancidas (an anti-fungal) and two vaccines — Pneumovax ... Hindu

Antibiotic-resistance gene spreads  -  Sep 21, 2007
...s Invanz antibiotic, and AstraZeneca Plc's Merrem, kill bacteria by breaking down their cell walls. The KPC gene makes an enzyme that breaks down the drugs ... Pay-Per-View - Newsday - ProQuest Archiver

RECALLS  -  Jul 15, 2007
Merck & Co. recalled three lots of the injectable antibiotic Invanz after broken glass was found in the solution on two occasions. Credit: Wire Reports. Pay-Per-View - Richmond Times - Dispatch - ProQuest Archiver

Stocks expected to move Thursday.  -  Dec 20, 2006
Merck & Co. said the Food and Drug Administration approved Invanz, an injectable antibiotic, for the prevention of surgical site infections after elective ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

国内碳é?’霉烯类开å?‘æ?¥åŠ¿æ±¹æ±¹  -  Jan 18, 2007
...éš?ç?€æˆ‘国与世界医è?¯å¸‚场的接轨,新è?¯çš„引入和产å“?å¼€å?‘速度较快。2005年默克新研制的 厄他培å?—也在中国获得注册,并以商å“?å??“INVANZâ€?(怡万之)上市。 ... 腾讯网

Merck and Paratek Pharmaceuticals Sign Collaboration Agreement for …  -  Mar 9, 2006
...market with CANCIDAS(R), INVANZ(R), and PRIMAXIN(R) and their legacy of innovating and delivering important new therapeutics to the marketplace." ... RedOrbit

ALSO NOTED: Vasogen to complete Phase III trials this year; Viventia...  -  Nov 13, 2005
Merck has received FDA approval to expand the use of Invanz for diabetic foot infections. Article. > The European Medicines Agency granted Pharmaxis orphan ... FierceBiotech

New drug to beat smoking approved.  -  Jan 16, 2007
...busulfan (trade name Busilvex) used to treat blood for a variety of conditions, and ertapenem (trade name Invanz) to treat diabetic foot infections. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Once-daily ertapenem good for diabetic foot infections.(Clinical...  -  Mar 1, 2005
The study was sponsored by Merck, which markets ertapenem (Invanz). The multicenter study enrolled adult men and women with diabetes and a moderate to ... Free with registration - Skin & Allergy News - AccessMyLibrary.com

ALSO NOTED: Repros reports positive data; Sanofi-Aventis would buy if...  -  Dec 20, 2006
The FDA has approved Merck's INVANZ, a once-daily injectable antibiotic, for a new indication: The prophylaxis of surgical site infection following elective ... FierceBiotech

'We are on the lookout for partnerships'  -  Oct 6, 2005
The drugs include Invanz (a new generation antibiotic used to treat gram positive and negative bacteria), Cancidas (anti-fungal drug), Pneumovax (pneumonia ... expresspharmapulse.com

Federal Register 2006 - 71 FR 62595 Pediatric Advisory Committee; …  -  Oct 26, 2006
...on adverse event reports for ertapenem (INVANZ), gemcitabine (GEMZAR), glimepiride (AMARYL), insulin aspart recombinant (NOVOLOG), linezolid (ZYVOX), ... Pay-Per-View - Federal Register 2006 - Loislaw

Top 200 drugs used in hospitals in 2006.(Table)  -  Apr 16, 2007
138 Ketorolac Tromethamine 62280168.57 -9.62 139 Solu-Medrol 61647510.79 13.48 140 Buminate 61488106.64 29.90 141 Invanz 61299527.56 49.15 142 Abelcet ... $4.95 - Drug Topics - ECNext

Ertapenem effective for diabetic foot infection: response to the...  -  Feb 1, 2005
The study was sponsored by Merck, which markets ertapenem (Invanz). The multicenter study enrolled adult men and women with diabetes and a moderate to ... Pay-Per-View - Family Practice News - HighBeam Research

Antibiotic gets new indication.(LATEBREAKERS)(Ertapenem)(Brief...  -  Jan 22, 2007
Ertapenem (Invanz, Merck) can now be used for the prophylaxis of surgical site infections following elective colorectal surgery. ... $4.95 - Drug Topics - ECNext

Press Release: Trius Therapeutics Recruits Merck Executive to Lead …  -  Jun 4, 2007
Infectious Disease Research for Merck, made major contributions to the development and registration of multiple marketed drugs including INVANZ(R), ... Pay-Per-View - PR Newswire - HighBeam Research

E coli urinary isolates likely multi-drug resistant: researchers...  -  Mar 1, 2006
Macrodantin) or the intravenous carbapenem ertapenem (Invanz), which demonstrated good activity against multi-drug-resistant isolates. ... $4.95 - Urology Times - ECNext

ISMP's list of error-prone abbreviations, symbols, and dose designatio...  -  Nov 1, 2005
...as Norflex "IV Vanc" intravenous vancomycin Mistaken as Invanz Symbols Intended Meaning Misinterpretation z Dram Symbol for dram mistaken as "3" [? ... $4.95 - Nephrology Nursing Journal - ECNext

Clinical News: Scottish Medicines Consortium approvals.  -  Oct 13, 2007
The Consortium has also approved ertapenem (Invanz, MSD) in preventing surgical site infection following colorectal surgery, and the formoterol inhaler ... $9.94 - Chemist & Druggist - Alacra Store

Article: Once-daily ertapenem good for diabetic foot infections.(Clini...  -  Mar 1, 2005
The study was sponsored by Merck, which markets ertapenem (Invanz). The multicenter ... Read all of this article with a FREE trial ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Ertapenem effective for diabetic foot infections: once-daily ertapenem...  -  Feb 15, 2005
The study was sponsored by Merck, which markets ertapenem (Invanz). The multicenter study enrolled adult men and women with diabetes and a moderate to ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

Merck & Co returns to India.(pharmaceuticals)(Brief Article)  -  Aug 1, 2005
Merck also has four products under registration in India: the antibiotic Invanz (ertapenem), the antifungal Cancidas (caspofungin) and two vaccines, ... $4.95 - Pharma Marketletter - ECNext

Trius Therapeutics Recruits Merck Executive to Lead Drug Development ...  -  Jun 4, 2007
Infectious Disease Research for Merck, made major contributions to the development and registration of multiple marketed drugs including INVANZ(R), ... $4.95 - PR Newswire - ECNext

Article: Ertapenem effective for diabetic foot infections: once-daily...  -  Feb 15, 2005
The study was sponsored by Merck, which markets ertapenem (Invanz). The ... Read all of this article with a FREE trial ... Pay-Per-View - Internal Medicine News - HighBeam Research

Merrill Lynch added as Buy  -  Nov 21, 2005
The Food and Drug Administration has expanded approval of Merck's ($30; NYSE: MRK) injectable antibiotic Invanz to treat foot infections associated with ... $1.95 - Dow Theory Forecasts - Horizon Publishing Company

Clinical News: Scottish Medicines Consortium approvals.(Brief article)  -  Oct 13, 2007
The Consortium has also approved ertapenem (Invanz, MSD) in preventing surgical site infection following colorectal surgery, and the formoterol inhaler ... $4.95 - Chemist & Druggist - ECNext

Article: ISMP's list of error-prone abbreviations, symbols, and dose ...  -  Nov 1, 2005
...as Norflex "IV Vanc" intravenous vancomycin Mistaken as Invanz Symbols Intended Meaning Misinterpretation z Dram Symbol for dram mistaken as "3" [? ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

DRUGS GIANT MERCK ANNOUNCES RETURN TO INDIA.  -  Jul 25, 2005
The products include Invanz, a second generation beta-lactam anti-biotic, Cancidas, an anti-fungal and two vaccines, Pneumovax (anti-pneumonia) and Varivax ... $4.95 - AsiaPulse News - ECNext

Revue de presse du Mercredi 8 juin 2005  -  Jun 8, 2005
Enfin, le CHMP recommande qu'Invanz® (ertapenem) de Merck MSD, utilisé pour le traitement d'infections bactériennes chez l'adulte (infections abdominales, ... Pharmaceutiques

Дорипенем — новое антибактериальное Ñ?редÑ?тво  -  Nov 19, 2007
Ð’ наÑ?тоÑ?щее времÑ? во многих Ñ?транах доÑ?тупны другие карбапенемы: Invanz (Ñ?ртапенем), Meronem/Меронем (меропенем), имепенем (Ñ? цилаÑ?татином — Tienam/Тиенам). ... Ð?птека online





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy